CTEC

Convatec sets out ‘Accelerate’ strategy to drive faster sustainable growth

Convatec has introduced its new Accelerate strategy, outlining four strategic pillars and reaffirming medium-term guidance including 6–8% annual organic revenue growth, a 24–26% adjusted operating margin and double-digit growth in..

Convatec reports 6.5% revenue growth and upgraded medium-term target

Convatec Group PLC reported FY2025 revenue of $2.44bn, up 6.5% on a reported basis, with adjusted operating profit rising 12.1% to $544m and adjusted EPS up 16%...

Convatec Group Plc launches $300m share buyback programme

Convatec has announced a non-discretionary share buyback of up to $300 million to return surplus capital to shareholders. The programme, managed by UBS AG London Branch, will run until 31..

Convatec Group welcomes CMS delay, ups FY25 InnovaMatrix® forecast

Convatec Group Plc celebrates the CMS's postponement of LCDs for diabetic foot ulcers, ensuring continued access to their trusted InnovaMatrix® for Medicare patients...

Convatec Group Plc reports broad-based, sustainable and profitable growth

Convatec Group Plc reports robust FY24 results with double-digit growth in EPS and cash flow, driven by strategic execution and expanded product offerings...

ConvaTec Group PLC 33.9% potential upside indicated by Berenberg Bank

ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 33.9% according to Berenberg Bank.CTEC.LBerenberg Bank set a target price of 310 GBX for the company, which when..

ConvaTec Group PLC 33.6% potential upside indicated by Berenberg Bank

ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 33.6% according to Berenberg Bank.CTEC.LBerenberg Bank set a target price of 310 GBX for the company, which when..

ConvaTec Group PLC 31.4% potential upside indicated by Berenberg Bank

ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 31.4% according to Berenberg Bank.CTEC.LBerenberg Bank set a target price of 310 GBX for the company, which when..

ConvaTec Group PLC 27.5% potential upside indicated by Berenberg Bank

ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 27.5% according to Berenberg Bank.CTEC.LBerenberg Bank set a target price of 310 GBX for the company, which when..

ConvaTec Group PLC 11.6% potential upside indicated by JP Morgan

ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 11.6% according to JP Morgan.JP Morgan set a target price of 323 GBX for the company, which when..

ConvaTec Group PLC 13.7% potential upside indicated by JP Morgan

ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 13.7% according to JP Morgan.JP Morgan set a target price of 323 GBX for the company, which when..

ConvaTec Group reports accelerating organic revenue growth of 7.2%

ConvaTec Group plc (LON:CTEC) reports strong annual results with 7.2% organic revenue growth, margin expansion and new product launches...

ConvaTec Group PLC 28.4% potential upside indicated by Berenberg Bank

ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 28.4% according to Berenberg Bank.Berenberg Bank set a target price of 290 GBX for the company, which when..

ConvaTec Group PLC 36.5% potential upside indicated by RBC Capital Markets

ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 36.5% according to RBC Capital Markets.RBC Capital Markets set a target price of 300 GBX for the company,..

ConvaTec Group PLC 35.4% potential upside indicated by RBC Capital Markets

ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 35.4% according to RBC Capital Markets.RBC Capital Markets set a target price of 300 GBX for the company,..

ConvaTec Group PLC 33.3% potential upside indicated by Barclays

ConvaTec Group PLC with ticker (LON:CTEC) now has a potential upside of 33.3% according to Barclays.Barclays set a target price of 310 GBX for the company, which when compared to..

Convatec increases revenue guidance

Convatec Group plc (LON:CTEC), a global medical products and technologies company, has announced a trading update for the four months ended 30 April 2023. Revenue increased by 3.1% on an..

Convatec acquires anti-infective nitric oxide technology platform

Convatec Group Plc [LON:CTEC] has announced it has acquired the anti-infective nitric oxide technology platform of 30 Technology Limited which includes new product assets and research and development. In addition..

Convatec appoints Citigroup Global Markets Limited as joint corporate broker

Convatec Group Plc (LON:CTEC), a global medical products and technologies company, has announced the appointment of Citigroup Global Markets Limited as joint corporate broker, to work alongside its existing broker..

Convatec to host Capital Markets Event this afternoon

Convatec Group plc (LON:CTEC) will host a Capital Markets Event this afternoon, 17 November 2022. Convatec’s Executive Leadership Team, including Chief Executive Officer, Karim Bitar, and Chief Financial Officer, Jonny..

Search

Funds

CTEC

Convatec sets out ‘Accelerate’ strategy to drive faster sustainable growth

Convatec has introduced its new Accelerate strategy, outlining four strategic pillars and reaffirming medium-term guidance including 6–8% annual organic revenue growth, a 24–26% adjusted operating margin and double-digit growth in adjusted EPS and free cash flow to equity...

Convatec reports 6.5% revenue growth and upgraded medium-term target

Convatec Group PLC reported FY2025 revenue of $2.44bn, up 6.5% on a reported basis, with adjusted operating profit rising 12.1% to $544m and adjusted EPS up 16%...

Convatec Group Plc launches $300m share buyback programme

Convatec has announced a non-discretionary share buyback of up to $300 million to return surplus capital to shareholders. The programme, managed by UBS AG London Branch, will run until 31 December 2025 and aims to reduce the company’s share capital, with purchased shares either cancelled or held in treasury for employee plans...

Convatec Group welcomes CMS delay, ups FY25 InnovaMatrix® forecast

Convatec Group Plc celebrates the CMS's postponement of LCDs for diabetic foot ulcers, ensuring continued access to their trusted InnovaMatrix® for Medicare patients...

Convatec Group Plc reports broad-based, sustainable and profitable growth

Convatec Group Plc reports robust FY24 results with double-digit growth in EPS and cash flow, driven by strategic execution and expanded product offerings...

ConvaTec Group reports accelerating organic revenue growth of 7.2%

ConvaTec Group plc (LON:CTEC) reports strong annual results with 7.2% organic revenue growth, margin expansion and new product launches...
Search

Funds

CTEC

FTSE 100

Funds